THOMAS JEFFERSON UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1824-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.jefferson.edu
Nursing-Driven Primary Palliative Care for Urban-Dwelling African Americans With Chronic Lung Disease
Not Applicable
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Other: Telehealth Integrated Primary Care (TIPC)
- First Posted Date
- 2022-11-09
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 23
- Registration Number
- NCT05611125
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)
Not Applicable
Withdrawn
- Conditions
- Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
- Interventions
- Procedure: Magnetic Resonance ImagingProcedure: Computed TomographyOther: Best PracticeOther: Virtual Technology InterventionOther: Questionnaire Administration
- First Posted Date
- 2022-10-31
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Thomas Jefferson University
- Registration Number
- NCT05600556
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Mobile Intervention to Improve Adherence of Oral Anti-cancer Medications Among Acute Myeloid Leukemia Patients, the txt4AML Study
Not Applicable
Withdrawn
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Other: Text Message-Based Navigation InterventionOther: Behavioral, Psychological or Informational InterventionOther: Survey AdministrationOther: Quality-of-Life Assessment
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Thomas Jefferson University
- Registration Number
- NCT05595135
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome
Phase 1
Active, not recruiting
- Conditions
- Myelodysplastic SyndromeRecurrent Myelodysplastic SyndromeRefractory Myelodysplastic Syndrome
- Interventions
- Procedure: Bone Marrow BiopsyProcedure: Biospecimen CollectionOther: Laboratory Biomarker AnalysisOther: Quality-of-Life Assessment
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 6
- Registration Number
- NCT05564650
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Neuroimaging Ancillary Study
Completed
- Conditions
- Iron Deficiency AnemiaIron Deficiency Anemia of PregnancyChild DevelopmentNeurodevelopmental Disorder of FoetusIron Deficiency Anemia TreatmentFetal Neurodevelopmental Disorder
- Interventions
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 184
- Registration Number
- NCT05545527
- Locations
- 🇮🇳
Jawaharlal Nehru Medical College, Belgaum, Karnataka, India
COVID Booster in Pregnancy and Lactation
Recruiting
- Conditions
- COVID-19
- Interventions
- Drug: Bivalent COVID-19 Booster
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 200
- Registration Number
- NCT05543993
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
A Chatbot-Powered G8 Screening Intervention to Facilitate Referrals to a Comprehensive Geriatric Assessment Among Older Adults With Cancer
Completed
- Conditions
- Geriatric Cancer Patients
- Interventions
- Other: G8 Screening Tool
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 100
- Registration Number
- NCT05535140
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Study of Low-dose Naltrexone in Chronic Migraine With Fibromyalgia
Recruiting
- Conditions
- FibromyalgiaChronic MigraineNew Daily Persistent Headache
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 30
- Registration Number
- NCT05536050
- Locations
- 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States
Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions
Phase 1
Terminated
- Conditions
- LeukoplakiaErythroplakiaOral Cavity CarcinomaProliferative Verrucous Leukoplakia
- Interventions
- Procedure: Biopsy
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 4
- Registration Number
- NCT05536037
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Telehealth-enabled Integrated Palliative Care for People With Dementia
Not Applicable
Completed
- Conditions
- Alzheimer DiseaseVascular Cognitive ImpairmentDementia of Alzheimer TypeLewy Body DementiaVascular DementiaFrontotemporal DegenerationMixed Dementia
- Interventions
- Other: Telehealth Integrated Primary Care (TIPC)
- First Posted Date
- 2022-09-01
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 50
- Registration Number
- NCT05524181
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath